Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs AVAV✓SelectedUSD · AVAVGSK vs AVAV performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs AVAV

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+65.3%
AVAV return
-3.9%
Excess return
+69.2%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioAVAVExcessAlpha
1D+0.5%-2.7%+3.3%+0.5%
7D+1.1%+4.2%-3.1%+1.1%
30D+6.3%-2.6%+8.9%+6.3%
3M+1.8%-38.0%+39.8%+1.9%
6M+1.7%-27.0%+28.7%+1.8%
YTD+6.5%-51.4%+58.0%+6.5%
1Y+9.5%-60.2%+69.7%+9.2%
3Y+65.3%-6.7%+72.0%+64.0%
All+65.3%-3.9%+69.2%+64.0%

Cumulative growth

Daily Returns

Daily percentage return beside AVAV.

Daily Out/Under-Performance

Portfolio return minus AVAV return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × AVAV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded AVAV wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling